Avoiding Costly Government Pricing MistakesBasic steps pharmaceutical manufacturers should employ to avoid erroneous government pricing calculationsManaging Government Pricing (GP) computations can feel a bit like walking through a cave without a flashlight. Even an...
White Paper
Continued Emergence of Drug Price Disclosure Legislation – January 2020
Continued Emergence of Drug Price Disclosure LegislationTips for staying compliant with an accelerating trendThe summer of 2019 saw an 86 percent increase in the number of states enacting pharmaceutical drug price disclosure laws. This paper, our second in a series...
Drug Price Disclosure Legislation – April 2019
Drug Price Disclosure LegislationFour steps to staying ahead and staying compliantMany states have moved to enact mandatory pharmaceutical price disclosure laws that would increase price transparency to address prescription drug costs (Fig. 1, pg. 3). In 2018, states...